Pharmocann Global Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
PMCN
IL0010968902
Healthcare Facilities & Services
Sales 2022 | 22.66M 6.04M 8.27M | Sales 2023 | 14.41M 3.84M 5.26M | Capitalization | 3.12M 832K 1.14M |
---|---|---|---|---|---|
Net income 2022 | -25M -6.67M -9.13M | Net income 2023 | -9M -2.4M -3.29M | EV / Sales 2022 | 0.4 x |
Net cash position 2022 | 925K 247K 338K | Net cash position 2023 | 768K 205K 280K | EV / Sales 2023 | 0.16 x |
P/E ratio 2022 |
-0.26
x | P/E ratio 2023 |
-0.28
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 51.05% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 19-06-16 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 19-12-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Guy Sigura
CHM | Chairman | 47 | 22-12-04 |
Locar Gila
BRD | Director/Board Member | 51 | 22-11-28 |
Director/Board Member | 43 | 22-11-28 |
1st Jan change | Capi. | |
---|---|---|
+29.90% | 268M | |
+44.86% | 283M | |
+50.00% | 195M | |
+43.48% | 130M | |
-28.57% | 121M | |
+115.91% | 121M | |
-36.75% | 130M | |
0.00% | 87.06M | |
+150.00% | 75.33M |